Tipranavir

Generic name: Tipranavir
Brand names: Aptivus
Dosage form: oral capsule (250 mg)
Drug class: Protease inhibitors

Usage of Tipranavir

Tipranavir an antiviral medicine that is used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). Tipranavir is not a cure for HIV or AIDS.

Tipranavir is used together with another drug called ritonavir.

Tipranavir may also be used for purposes not listed in this medication guide.

Tipranavir side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some people taking tipranavir with ritonavir have developed fatal medical problems including liver damage and bleeding in the brain. Stop taking tipranavir and get emergency medical attention if you have:

right-sided upper stomach pain, nausea, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); or

unusual bleeding, sudden severe headache, problems with speech or vision.

Tipranavir may cause serious side effects. Call your doctor at once if you have:

severe skin rash, blistering, peeling, redness or sunburn;

skin rash and also joint or muscle pain, fever, or tightness in your throat; or

increased thirst, increased urination, hunger, dry mouth.

Tipranavir affects your immune system, which may cause certain side effects (even weeks or months after you've taken this medicine). Tell your doctor if you have:

signs of a new infection--fever, night sweats, swollen glands, cold sores, cough, wheezing, diarrhea, weight loss;

trouble speaking or swallowing, problems with balance or eye movement, weakness or prickly feeling; or

swelling in your neck or throat (enlarged thyroid), menstrual changes, impotence.

Common side effects of tipranavir may include:

nausea, vomiting, diarrhea, stomach pain;

skin rash (especially in children);

headache, fever, tired feeling; or

changes in the shape or location of body fat (especially in your arms, legs, face, neck, breasts, and waist).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Tipranavir

You should not use tipranavir if you are allergic to it, or if you have:

moderate to severe liver disease.

Some medicines can cause unwanted or dangerous effects when used with tipranavir. Your doctor may change your treatment plan if you also use:

alfuzosin;

cisapride;

lurasidone;

pimozide;

rifampin;

sildenafil (Revatio for pulmonary arterial hypertension);

St. John's wort;

ergot medicine--dihydroergotamine, ergotamine, ergonovine, methylergonovine;

heart medication--amiodarone, flecainide, propafenone, quinidine;

a sedative--oral midazolam, triazolam; or

"statin" cholesterol medicine--atorvastatin, lovastatin, simvastatin.

Tell your doctor if you have ever had:

liver disease (especially hepatitis B or C);

diabetes;

high cholesterol or triglycerides;

a bleeding disorder such as hemophilia; or

an allergy to sulfa drugs.

Tell your doctor if you are pregnant, and use your medications properly to control your infection. HIV can be passed to your baby if the virus is not controlled during pregnancy. Your name may be listed on a registry to track any effects of antiviral medicine on the baby.

Tipranavir can make birth control pills less effective. Ask your doctor about using a non-hormonal birth control (condom, diaphragm with spermicide) to prevent pregnancy.

Women with HIV or AIDS should not breast feed a baby. Even if your baby is born without HIV, the virus may be passed to the baby in your breast milk.

Tipranavir should not be given to a child younger than 2 years old.

Relate drugs

How to use Tipranavir

Usual Adult Dose for HIV Infection:

Tipranavir 500 mg plus ritonavir 200 mg orally twice a dayUse: In combination with ritonavir and other antiretrovirals, for the treatment of HIV-1 infection in therapy-experienced patients infected with HIV-1 strains resistant to more than 1 protease inhibitor

Usual Pediatric Dose for HIV Infection:

2 to 18 years:-Based on weight: Tipranavir 14 mg/kg plus ritonavir 6 mg/kg orally twice a day-Based on BSA: Tipranavir 375 mg/m2 plus ritonavir 150 mg/m2 orally twice a dayMaximum dose: Tipranavir 500 mg/dose plus ritonavir 200 mg/doseComments:-Special vigilance recommended during dose calculation, medication order transcription, dispensing information, and dosing instructions to reduce risk for medication errors, overdose, and underdose.-Pediatric dose should not exceed the usual adult dose.Use: In combination with ritonavir and other antiretrovirals, for the treatment of HIV-1 infection in therapy-experienced patients infected with HIV-1 strains resistant to more than 1 protease inhibitor

Warnings

You should not use tipranavir if you have moderate to severe liver disease.

Tell your doctor about all your current medicines and any you start or stop using. Many drugs can interact, and some drugs should not be used together.

Some people taking tipranavir with ritonavir have developed fatal medical problems including liver damage and bleeding in the brain. Stop taking these medicines and get emergency medical attention if you have: right-sided upper stomach pain, nausea, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes), unusual bleeding, sudden severe headache, or problems with speech or vision.

What other drugs will affect Tipranavir

Many drugs can affect tipranavir, and some drugs should not be used at the same time. Tell your doctor about all your current medicines and any medicine you start or stop using. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.